NGS 2013 Manchester: Applications & Bottlenecks
5th – 6th November 2013 Manchester, United Kingdom
The aim of our NGS conferences is to address key issues being faced by laboratories that are implementing Next Generation Sequencing (NGS) into their workflows. Whilst NGS is a very powerful technology that holds the promise of unlocking the secrets of DNA sequences on a large scale, its implementation has not been as smooth as anticipated.
Our previous co-organized event in this area – NGS2013 Oxford Workshop & Symposium – focussed on bioinformatics, but with the current NGS conference in Manchester we want to take the theme a step further by broadening the discussion areas
Whether your laboratory is working in the area of clinical genetics, animal, plant or microbial genetics you will be aware that there are common issues that unite researchers in all of these fields when it comes to establishing workflows for NGS. These issues which have become recognized bottlenecks across all areas of NGS based research include but are not limited to Library generation, Data analysis and Data storage. Whilst these issues are now being addressed by start-up as well as established biotech companies, they are being tackled in isolation of the entire NGS workflow.
The NGS 2013 Manchester conference will bring together leading experts from widely diverse backgrounds to tackle these issues by networking, discussing the common bottlenecks and working with biotech companies to try and mitigate these issues. We strive to keep our conferences informal and create a good personal atmosphere so as to facilitate dialogue and networking amongst all participants.
The result is an NGS conference that gather researchers from Pharma, Biotech, Hospitals and Universities who are working in areas and applications that benefit each other when discussed in the context of common NGS bottlenecks. Researchers working in the areas of micro RNA’s, Exome & Genomic sequencing, NGS panels, inherited diseases, expression analysis, viral genomics to name but a few areas can now listen to each other and find effective strategies and partners that will help in ironing out the bottlenecks.
Who should attend:
1. All NGS users, researchers and students
3. NHS Labs and private companies, Pharma, Biotech and Agro Companies
Geneticists interested in the latest developments of:
• Computational Biology
• Data Analysis
• Data interpretation
• DNA Sequencing
• Infectious and inherited Diseases
• Molecular and Cell Biology
• Molecular Diagnostics
• Next Generation Sequencing